Circular RNA Ubiquitin-associated Protein 2 Silencing Suppresses Bladder Cancer Progression by Downregulating DNA Topoisomerase 2-alpha Through Sponging miR-496

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 National Health Commission of the People’s Republic of China. Chinese guidelines for diagnosis and treatment of urothelial carcinoma of bladder 2018 (English version). Chin J Cancer Res 2019;31:49–66. Dreicer, 2017, Chemotherapy for advanced urothelial cancer: end of the beginning?, Lancet Oncol, 18, 567, 10.1016/S1470-2045(17)30241-3 Alifrangis, 2019, Molecular and histopathology directed therapy for advanced bladder cancer, Nat Rev Urol, 16, 465, 10.1038/s41585-019-0208-0 Geng, 2018, Function and clinical significance of circRNAs in solid tumors, J Hematol Oncol, 11, 98, 10.1186/s13045-018-0643-z Chen, 2015, Regulation of circRNA biogenesis, RNA Biol, 12, 381, 10.1080/15476286.2015.1020271 Yu, 2019, The emerging roles and functions of circular RNAs and their generation, J Biomed Sci, 26, 29, 10.1186/s12929-019-0523-z Liu, 2020, Insights into the regulatory role of circRNA in angiogenesis and clinical implications, Atherosclerosis, 298, 14, 10.1016/j.atherosclerosis.2020.02.017 Li, 2018, The biogenesis, functions, and challenges of circular RNAs, Mol Cell, 71, 428, 10.1016/j.molcel.2018.06.034 Zhang, 2016, The biogenesis of nascent circular RNAs, Cell Rep, 15, 611, 10.1016/j.celrep.2016.03.058 Su, 2020, circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway, Mol Cancer, 19, 23, 10.1186/s12943-019-1129-5 Lu, 2019, Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN, Mol Cancer, 18, 111, 10.1186/s12943-019-1040-0 Xie, 2018, Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis, Mol Cancer, 17, 144, 10.1186/s12943-018-0892-z Wang, 2020, Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis, Aging, 12, 9793, 10.18632/aging.103244 Shen, 2020, Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients, Cancer Med, 9, 3885, 10.1002/cam4.3006 Hansen, 2013, Natural RNA circles function as efficient microRNA sponges, Nature, 495, 384, 10.1038/nature11993 Thomson, 2016, Endogenous microRNA sponges: evidence and controversy, Nat Rev Genet, 17, 272, 10.1038/nrg.2016.20 Liang, 2020, LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis, Mol Cancer, 19, 85, 10.1186/s12943-020-01206-5 Lee, 2018, Molecular targeted therapy: treating cancer with specificity, Eur J Pharmacol, 834, 188, 10.1016/j.ejphar.2018.07.034 Pérez-Herrero, 2015, Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy, Eur J Pharm Biopharm, 93, 52, 10.1016/j.ejpb.2015.03.018 He, 2021, Targeting circular RNAs as a therapeutic approach: current strategies and challenges, Signal Transduct Target Ther, 6, 185, 10.1038/s41392-021-00569-5 Jeck, 2013, Circular RNAs are abundant, conserved, and associated with ALU repeats, RNA (New York, NY), 19, 141, 10.1261/rna.035667.112 Lunt, 2011, Aerobic glycolysis: meeting the metabolic requirements of cell proliferation, Annu Rev Cell Dev Biol, 27, 441, 10.1146/annurev-cellbio-092910-154237 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Liberti, 2016, The Warburg effect: how does it benefit cancer cells?, Trends Biochem Sci, 41, 211, 10.1016/j.tibs.2015.12.001 Goncalves, 2018, A glycolysis outsider steps into the cancer spotlight, Cell Metab, 28, 3, 10.1016/j.cmet.2018.06.017 Su, 2021, miR-496 inhibits proliferation via LYN and AKT pathway in gastric cancer, Open Med, 16, 1206, 10.1515/med-2021-0313 Lee, 2021, MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1, Medicine, 100, e25270, 10.1097/MD.0000000000025270 Ma, 2019, miR-496 suppress tumorigenesis via targeting BDNF-mediated PI3K/Akt signaling pathway in non-small cell lung cancer, Biochem Biophys Res Commun, 518, 273, 10.1016/j.bbrc.2019.08.046 Wu, 2019, Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression, Aging, 11, 12624, 10.18632/aging.102591 Woessner, 1991, Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells, Cell Growth Differ, 2, 209 Farr, 2014, The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells, Nucleic Acids Res, 42, 4414, 10.1093/nar/gku076 Sønderstrup, 2015, Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers, Mol Oncol, 9, 1207, 10.1016/j.molonc.2015.02.009 Deng, 2015, The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells, Br J Pharmacol, 172, 2246, 10.1111/bph.13046 Chen, 2015, Topoisomerase IIα in chromosome instability and personalized cancer therapy, Oncogene, 34, 4019, 10.1038/onc.2014.332 Liu, 2019, Mutual regulation of MDM4 and TOP2A in cancer cell proliferation, Mol Oncol, 13, 1047, 10.1002/1878-0261.12457 Pei, 2018, TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway, Biochim Biophys Acta Mol Basis Dis, 1864, 197, 10.1016/j.bbadis.2017.10.019 Zeng, 2019, Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms, BMC Cancer, 19, 604, 10.1186/s12885-019-5814-y Zhang, 2021, MiR-599 targeting TOP2A inhibits the malignancy of bladder cancer cells, Biochem Biophys Res Commun, 570, 154, 10.1016/j.bbrc.2021.06.069